- Status:
- In progress
- Technology type:
- Medicine
- Decision:
- Selected
- Reason for decision:
- Anticipate the topic will be of importance to patients, carers, professionals, commissioners and the health of the public to ensure clinical benefit is realised, inequalities in use addressed, and help them make the best use of NHS resources
- Process:
- STA Standard
- ID number:
- 11905
Provisional Schedule
- Expected publication:
- 10 June 2026
Project Team
- Project lead
- Jeremy Powell
Email enquiries
If you have any queries please email TACommB@nice.org.uk
- External Assessment Group:
- Centre for Reviews and Dissemination and Centre for Health Economics, University of York
Stakeholders
- Companies sponsors
- Madrigal Pharmaceuticals (resmetirom)
- Others
- Department of Health and Social Care
- NHS England
- Patient carer groups
- British Liver Trust
- Professional groups
- British Association for the Study of the Liver (BASL)
- British Hepatology Pharmacy Group
- Royal College of Physicians
- UK Clinical Pharmacy Association
- Associated public health groups
- Public Health Wales
- UK Health Security Agency
- Comparator companies
- Alliance Pharmaceuticals (vitamin E) - confidentiality agreement not signed, not participating
- Brown & Burk UK (pioglitazone) - confidentiality agreement not signed, not participating
- Kora Healthcare (vitamin E) - confidentiality agreement not signed, not participating
- Mylan (pioglitazone) - confidentiality agreement not signed, not participating
- Neon Healthcare (pioglitazone) - confidentiality agreement not signed, not participating
- Novo Nordisk Ltd (semaglutide)
- Sandoz (pioglitazone) - confidentiality agreement not signed, not participating
- General commentators
- All Wales Therapeutics and Toxicology Centre
- British National Formulary
- Department of Health - Northern Ireland
- Healthcare Improvement Scotland
- Medicines and Healthcare products Regulatory Agency
- Scottish Medicines Consortium
- Welsh Government
Timeline
Key events during the development of the guidance:
| Date | Update |
|---|---|
| 14 May 2026 | Committee meeting: 1 |
| 29 December 2025 | A Technical Engagement consultation took place with registered stakeholders. The Committee meeting was delayed to allow more time for this appraisal. - Note added to the project documents |
| 12 December 2025 | Note - Note added to the project documents |
| 10 July 2025 | Invitation to participate |
| 10 July 2025 | In progress. Final scope published. |
| 16 April 2025 | Referral |
| 11 April 2025 | Note added to the project documents |
| 13 September 2023 | Awaiting development. Status change linked to Topic Selection Decision being set to Selected |
For further information on our processes and methods, please see our CHTE processes and methods manual